The price of this share is at 5,83$, Emergent Biosolutions Inc, with address at 400 PROFESSIONAL DRIVE SUITE 400, GAITHERSBURG, Maryland, 21079, United States, is a publicly traded company and its visible heads at the moment are Adam Robert Havey (Chief Operating Officer & Executive Vice President), Christopher H. Cabell (Head-Clinical Development), Karen L. Smith (Chief Medical Officer), Richard Scott Lindahl (Chief Financial Officer, Treasurer & Executive VP), Robert G. Kramer (President, Chief Executive Officer & Director), Sharon M. Solomon (Chief Information Officer & Senior Vice President). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 5,73$ - 6,26$, with a percentage difference of 6,00$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
